M, P., B, M., L, M., B, P., E, G., C, B., . . . JA, P. (2025). Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: Experience from the clinical practice. Breast cancer research and treatment, 210(3), 507. https://doi.org/10.1007/s10549-025-07643-4
Chicago Style (17th ed.) CitationM, Potrony, et al. "Considerations for Hereditary Breast and Ovarian Cancer Syndrome Molecular Diagnosis: Experience from the Clinical Practice." Breast Cancer Research and Treatment 210, no. 3 (2025): 507. https://doi.org/10.1007/s10549-025-07643-4.
MLA (9th ed.) CitationM, Potrony, et al. "Considerations for Hereditary Breast and Ovarian Cancer Syndrome Molecular Diagnosis: Experience from the Clinical Practice." Breast Cancer Research and Treatment, vol. 210, no. 3, 2025, p. 507, https://doi.org/10.1007/s10549-025-07643-4.